Targeted detection for patients with Alpha-1-Antitrypsin deficiency: perspectives from Spain and the USA

M. Miravitlles (Barcelona, Spain), C. Strange (Charleston, United States of America)

Source: Annual Congress 2010 - How to improve the level of clinical evidence in orphan lung diseases
Session: How to improve the level of clinical evidence in orphan lung diseases
Session type: Evening Symposium
Number: 1873

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Miravitlles (Barcelona, Spain), C. Strange (Charleston, United States of America). Targeted detection for patients with Alpha-1-Antitrypsin deficiency: perspectives from Spain and the USA. Annual Congress 2010 - How to improve the level of clinical evidence in orphan lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Targeted literature review: epidemiology of severe and uncontrolled asthma and associated biomarkers in France, Germany, Italy, Spain and the UK
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


Targeted literature review: burden of disease associated with severe and uncontrolled asthma in France, Germany, Italy, Spain and the UK
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


Late Breaking Abstract - A New study of the Prevalence of COPD in Spain: EPISCAN II
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019

The incidence of severe alpha-1-antitrypsin (AAT) deficiency alleles in COPD patients – Update from Central Eastern European (CEE) AAT Network
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014

α1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001
Source: Eur Respir J 2002; 20: 1050-1056
Year: 2002



The costs of MDR/XDR tuberculosis in Barcelona (Spain): Cases treated with DOTs/DOT plus in a specialized centre
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016

Late Breaking Abstract - Prevalence, characterization and costs of severe asthma in Spain (BRAVO 1)
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020




Late Breaking Abstract - Analysing the COPD care pathway in Japan, Canada, England and Germany: pilot study results
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Retrospective analysis of patients with diffuse parenchimal lung diseases (dpld) admitted to San Camillo-Forlanini Hospital in Rome (Italy)
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

Treatment outcomes of new TB cases among children in Russia
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Detection of alpha1-antitrypsin deficiency in a European country without national registry yet
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016

Management of patients with M/XDR-tuberculosis in Europe
Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Year: 2015



Correlation between Performance Status (PS) assessment between clinicians and oncologists in a United Kingdom (UK) District General Hospital (DGH) Lung cancer service
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019

Mutational screening in Italian patients with primary ciliary dyskinesia by next-generation sequencing (NGS)
Source: International Congress 2016 – Highlights in primary ciliary dyskinesia and asthma in childhood
Year: 2016

The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population - results from large scale newborn screening
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014

Late Breaking Abstract - Response of the paediatric Long Term Ventilation (LTV) department of Cambridge University Hospital (CUH) during the Covid-19 pandemic: challenges and lessons.
Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness
Year: 2021


Late Breaking Abstract - Asthma prevalence and management in adults in France in 2018: ASTHMAPOP survey
Source: International Congress 2018 – Asthma in children and adults: long-term aspects
Year: 2018



Analysis of the patients with community acquired pneumonia treated in MHAT “St. Marina”, Varna, Bulgaria for the 2011–2012 period
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Molecular diagnosis of Alpha-1 antitrypsin deficiency: a new method based on Luminex Technology
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017


Immunological status of children with atopical and nonatopical asthma from West Germany (Bonn)
Source: Eur Respir J 2005; 26: Suppl. 49, 588s
Year: 2005